E7050 in Combination With E7080 in Subjects With Advanced Solid Tumors (Dose Escalation) and in Subjects With Recurrent Glioblastoma or Unresectable Stage III or Stage IV Melanoma After Prior Systemic Therapy (Expansion Cohort and Phase 2)
This study is currently recruiting participants.
Verified September 2012 by Eisai Inc.
Study NCT01433991
Information provided by Eisai Inc.
First Received on September 7, 2011.
Last Updated on May 10, 2013
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
